ReproCyc ParvoFLEX
porcine parvovirosis vaccine (inactivated)
Table of contents
Overview
ReproCyc ParvoFLEX is a veterinary vaccine given to female pigs to protect their unborn piglets from porcine parvovirus infection via the placenta. Porcine parvovirus causes infertility, still births and small litters in female pigs. ReproCyc ParvoFLEX contains inactivated (killed) porcine parvovirus strain 27a viral protein 2.
Authorisation details
Product details | |
---|---|
Name |
ReproCyc ParvoFLEX
|
Agency product number |
EMEA/V/C/004858
|
Active substance |
Porcine parvovirus, strain 27a, viral protein 2
|
International non-proprietary name (INN) or common name |
porcine parvovirosis vaccine (inactivated)
|
Species |
Pigs
|
Anatomical therapeutic chemical veterinary (ATCvet) codes |
QI09AA02
|
Publication details | |
---|---|
Marketing-authorisation holder |
Boehringer Ingelheim Vetmedica GmbH
|
Revision |
1
|
Date of issue of marketing authorisation valid throughout the European Union |
26/04/2019
|
Contact address |
Binger Strasse 173 |
Product information
30/10/2019 ReproCyc ParvoFLEX - EMEA/V/C/004858 - IA/0002/G
This medicine’s product information is available in all official EU languages.
Select ‘available languages’ to access the language you need.
Product information documents contain:
- summary of product characteristics (annex I);
- manufacturing authorisation holder responsible for batch release (annex IIA);
- conditions of the marketing authorisation (annex IIB);
- labelling (annex IIIA);
- package leaflet (annex IIIB).
You can find product information documents for centrally authorised human medicines on this website. For centrally authorised veterinary medicines authorised or updated from February 2022, see the Veterinary Medicines Information website.
Pharmacotherapeutic group
Immunologicals for suidae
Therapeutic indication
For active immunisation of gilts and sows from the age of 5 months to protect progeny against transplacental infection caused by porcine parvovirus.